Press releases | WebDisclosure

Basculer en Français

9743	Companies
194612	Keywords
125723	Articles
103520	Press releases

Home
Press releases

PRESS RELEASE

published on 02/13/2025 at 07:02, 11 months 13 days ago

Commerzbank delivers record profit – strong momentum for accelerated growth and transformation – targeting 15% return on tangible equity by 2028
Commerzbank delivers record profit in 2024, exceeding targets: net result increased by 20% to around €2.7 bn, operating result improved by 12% to €3.8 bn. Strategy upgrade set to target 15% return on tangible equity by 2028

Financial Results Return On Equity Commerzbank Record Profit Strategy Upgrade
REGULATED PRESS RELEASE

published on 02/13/2025 at 07:01, 11 months 13 days ago

bioMérieux lance GENE-UP® TYPER, une solution diagnostique innovante destinée aux industries agroalimentaires pour analyser rapidement l’origine des contaminations par Listeria monocytogenes
bioMérieux lance GENE-UP® TYPER, solution diagnostique PCR innovante pour identifier rapidement l’origine des contaminations par Listeria monocytogenes dans l'industrie agroalimentaire

BioMérieux Listeria Monocytogenes Diagnostic PCR GENE-UP® TYPER Contamination
REGULATED PRESS RELEASE

published on 02/13/2025 at 07:01, 11 months 13 days ago

bioMérieux launches GENE-UP® TYPER, an innovative diagnostic solution for food industries to rapidly analyze the root cause of contamination of Listeria monocytogenes
bioMérieux launches GENE-UP® TYPER, an innovative real-time PCR solution for rapid root cause analysis in food industries, targeting Listeria monocytogenes contamination

BioMérieux Listeria Monocytogenes GENE-UP® TYPER Real-time PCR Root Cause Analysis
PRESS RELEASE

published on 02/13/2025 at 07:00, 11 months 13 days ago

SCHOTT Pharma records good start into fiscal year and confirms full year outlook
SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55%

Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
PRESS RELEASE

published on 02/13/2025 at 07:00, 11 months 13 days ago

STRABAG SE starts new financial year with record order backlog
STRABAG SE announces record order backlog of €25.4 billion, with output volume at €19.2 billion in 2024. Outlook for 2025 includes output growth to around €21 billion and raised EBIT margin target to ≥4.5%

EBIT Margin Order Backlog STRABAG SE Output Volume 2025 Outlook
PRESS RELEASE

published on 02/13/2025 at 07:00, 11 months 13 days ago

KWS publishes results for the first half of 2024/2025 and confirms its forecasts
KWS publishes results for the first half of 2024/2025, with a 5% rise in net sales and confirmed forecasts. Key earnings indicators impacted by seasonality

Net Sales Earnings KWS Forecasts Results
PRESS RELEASE

published on 02/13/2025 at 07:00, 11 months 13 days ago

thyssenkrupp nucera Reports Strong Sales and EBIT Growth in First Quarter of New Fiscal Year
thyssenkrupp nucera reports strong sales and EBIT growth in the first quarter of the new fiscal year, driven by improved gross margins and ongoing R&D investments. Full-year outlook confirmed

Sales Growth R&D Investments Thyssenkrupp Nucera EBIT Growth Full-year Outlook
REGULATED PRESS RELEASE

published on 02/13/2025 at 07:00, 11 months 13 days ago

CHARGEURS - 2024 annual results and new strategic plan
REGULATED PRESS RELEASE

published on 02/13/2025 at 07:00, 11 months 13 days ago

CHARGEURS - Résultats annuels 2024 et nouvelle trajectoire stratégique
PRESS RELEASE

published on 02/13/2025 at 06:59, 11 months 13 days ago

Commerzbank delivers record profit – strong momentum for accelerated growth and transformation – targeting 15% return on tangible equity by 2028
Commerzbank exceeds 2024 targets with record profit, plans for accelerated growth and transformation, targeting 15% return on equity by 2028. Strategy upgrade includes increased focus on asset management and digitalization

Digitalization Transformation Growth Commerzbank Record Profit

Accesswire

Published on 01/26/2026 at 15:42, 2 hours 57 minutes ago

Greenlane to Deploy up to 30 Million Units of BERA Into Validator Infrastructure to Participate in Protocol-Level Yield Mechanisms, Bringing Total Validator Deployment to up to 50 Million Units
Published on 01/26/2026 at 15:30, 3 hours 9 minutes ago

Silver Spruce Announces Director and Officer Resignation
Published on 01/26/2026 at 14:00, 4 hours 39 minutes ago

Rare Earth Targets Refined as IP, MT, Radiometric and Geological Data Converge at Colosseum Project
Published on 01/26/2026 at 14:00, 4 hours 39 minutes ago

Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers
Published on 01/26/2026 at 13:45, 4 hours 54 minutes ago

Quartz Announces Significant Induced Polarization Survey Results for Maestro Gold-Silver Project, British Columbia

View all ACCESSWIRE

EQS Group

Published on 01/26/2026 at 18:00, 39 minutes ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.12.25.
Published on 01/26/2026 at 17:59, 40 minutes ago

PoPP draft specifications support seamless continuation of Redcare Pharmacy’s digital e-prescription journey.
Published on 01/26/2026 at 17:45, 54 minutes ago

Dr. Christian Schlögel nominated as new member of the Board of Directors
Published on 01/26/2026 at 17:40, 59 minutes ago

VALBIOTIS SA: Valbiotis launches an exclusive commercial benefit for its shareholders: a 20% discount on ValbiotisPRO® and ValbiotisPLUS® ranges
Published on 01/26/2026 at 17:40, 59 minutes ago

VALBIOTIS SA: Valbiotis lance un avantage commercial exclusif pour ses actionnaires : 20% de réduction sur ses gammes ValbiotisPRO® et ValbiotisPLUS®

Les Echos

Published on 01/26/2026 at 18:00, 39 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 20 et le 21 janvier 2026
Published on 01/26/2026 at 18:00, 39 minutes ago

Reporting on share buyback transactions carried out between January 20 and January 21, 2026
Published on 01/26/2026 at 17:45, 54 minutes ago

Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:45, 54 minutes ago

Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
Published on 01/26/2026 at 17:45, 54 minutes ago

Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments

View all LES ECHOS COMFI WIRE